Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: In vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737

被引：31

作者：

Ishitsuka, Kenji ^{[1
]}

Kunami, Naoko ^{[1
]}

Katsuya, Hiroo ^{[1
]}

Nogami, Rumiko ^{[1
]}

Ishikawa, Chie ^{[2
,3
]}

Yotsumoto, Fusanori ^{[4
]}

Tanji, Hiroe ^{[2
]}

Mori, Naoki ^{[2
]}

Takeshita, Morishige ^{[5
]}

Miyamoto, Shingo ^{[6
]}

Tamura, Kazuo ^{[1
]}

机构：

[1] Fukuoka Univ, Dept Internal Med, Div Med Oncol Hematol & Infect Dis, Fukuoka 8140180, Japan

[2] Univ Ryukyus, Grad Sch Med, Div Mol Virol & Oncol, Nishihara, Okinawa 9030215, Japan

[3] Univ Ryukyus, Transdisciplinary Res Org Subtrop & Isl Studies, Nishihara, Okinawa 9030215, Japan

[4] Fukuoka Univ, Sch Med, Dept Biochem, Fukuoka 8140180, Japan

[5] Fukuoka Univ, Sch Med, Dept Pathol, Fukuoka 8140180, Japan

[6] Fukuoka Univ, Dept Obstet & Gynecol, Fukuoka 8140180, Japan

来源：

CANCER LETTERS | 2012年 / 317卷 / 02期

关键词：

ATLL; Novel treatment; Bcl-2 family proteins; Apoptosis; ABT-737; ACUTE LYMPHOBLASTIC-LEUKEMIA; MULTIPLE-MYELOMA CELLS; BH3 MIMETIC ABT-737; NF-KAPPA-B; CONSTITUTIVE ACTIVATION; DOWN-REGULATION; X-L; APOPTOSIS; LYMPHOMA; SENSITIVITY;

D O I：

10.1016/j.canlet.2011.11.030

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Adult T-cell leukemia/lymphoma (ATLL) is a peripheral T-cell malignancy caused by human T-lymphotropic virus type 1 (HTLV-1). ABT-737, a small molecule inhibitor of Bcl-2, Bcl-X-L, and Bcl-w, significantly induced apoptosis in HTLV-1 infected T-cell lines as well as in fresh ATLL cells, and synergistically enhanced the cytotoxicity and apoptosis induced by conventional cytotoxic drugs. Moreover, ABT-737 significantly inhibited the in vivo tumor growth of an ATLL mouse model. These results suggest that the use of an agent targeting anti-apoptotic bcl-2 family proteins, either alone or in combination with other conventional drugs, represents a novel promising approach for ATLL (C) 2011 Elsevier Ireland Ltd. All rights reserved.

引用

页码：218 / 225

页数：8

共 46 条

[1] The role of NF-κB-1 and NF-κB-2-mediated resistance to apoptosis in lymphornas [J].

Bernal-Mizrachi, Leon ;

Lovly, Christine M. ;

Ratner, Lee .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (24) :9220-9225

[2] A novel Bcl-2/Bcl-XL/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma [J].

Chauhan, D. ;

Velankar, M. ;

Brahmandam, M. ;

Hideshima, T. ;

Podar, K. ;

Richardson, P. ;

Schlossman, R. ;

Ghobrial, I. ;

Raje, N. ;

Munshi, N. ;

Anderson, K. C. .

ONCOGENE, 2007, 26 (16) :2374-2380

[3] Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death [J].

Chen, R ;

Keating, MJ ;

Gandhi, V ;

Plunkett, W .

BLOOD, 2005, 106 (07) :2513-2519

[4] Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing bak activation and bax translocation [J].

Chen, Shuang ;

Dai, Yun ;

Harada, Hisashi ;

Dent, Paul ;

Grant, Steven .

CANCER RESEARCH, 2007, 67 (02) :782-791

[5] QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].

CHOU, TC ;

TALALAY, P .

ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55

[6] Promoting apoptosis as a strategy for cancer drug discovery [J].

Fesik, SW .

NATURE REVIEWS CANCER, 2005, 5 (11) :876-885

[7] Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma [J].

Fukushima, T ;

Miyazaki, Y ;

Honda, S ;

Kawano, F ;

Moriuchi, Y ;

Masuda, M ;

Tanosaki, R ;

Utsunomiya, A ;

Uike, N ;

Yoshida, S ;

Okamura, J ;

Tomonaga, M .

LEUKEMIA, 2005, 19 (05) :829-834

[8]

Gandhi L., 2011, J Clin Oncol

[9]

Gojo I, 2002, CLIN CANCER RES, V8, P3527

[10]

Hermine Olivier, 2002, Hematol J, V3, P276, DOI 10.1038/sj.thj.6200195

← 1 2 3 4 5 →